#$%^&*AU2018202701A120180705.pdf#####Abstract The present application discloses products (pharmaceutical compositions and dietary supplements) comprising a compound of formula I (for example, anatabine). - .Rb N Xa-l N Formula I wherein R represents hydrogen or C1 - C5 alkyl R represents hydrogen or C1 - C7 alkyl and X represents halogen or C1 - C1 alkyl, or a pharmaceutically acceptable salt thereof and the dotted line within piperidine ring B represents a carbon/carbon or carbon/nitrogen double bond or two conjugated double bonds selected independently from a carbon/nitrogen double bond and a carbon/carbon double bonds, wherein: when a carbon/nitrogen double bond is present, R is absent and either: (i) "a" is an integer ranging from 1-4 and "b" is an integer ranging from 0-8 or (ii) "a" is an integer ranging from 0-4 and "b" is an integer ranging from 1-8, and wherein when a carbon/nitrogen double bond is not present, R is present "a" is an integer ranging from 0-4 and "b" is an integer ranging from 0-8 and (b) a vitamin. The said products are useful for anti-inflammatory support.
